Hasan M, Parveen F, Shamsuzzaman A K, Kibria M D
Department of Surgery, Mymensingh Medical College, Mymensingh, Bangladesh.
Mymensingh Med J. 2007 Jul;16(2):154-9.
This prospective study was done to compare the efficacy of Tamsulosin and Finasteride for the medical treatment of symptomatic Benign Prostatic Hyperplasia (BPH) at the surgery and urology outpatient department of Mymensingh Medical College Hospital during the period from January 2003 to December 2004. Closely matched 70 patients in the age range of 50-80 years presented with lower urinary tract symptoms and clinically diagnosed as BPH were selected in the present study. Among them, 36 patients (Group I) and 34 patients (Group II) were treated with Tamsulosin (0.4 mg once daily) and Finasteride (5 mg once daily) for a duration of 06 months respectively. The efficacy of two drugs was compared on the basis of IPSS and Qmax. The base-line parameters of both groups were statistically insignificant. A significant improvement of IPSS and Qmax was found after 06 months of treatment in both groups (P<0.001). A significant improvement of IPSS Qmax was found in both groups (p<0.001) during follow-up at 1st, 2nd, 4th and 6th month. It was also observed that Tamsulosin improved the IPSS and Qmax more quickly than Finasteride.
本前瞻性研究旨在比较坦索罗辛和非那雄胺在2003年1月至2004年12月期间于迈门辛医学院医院外科和泌尿外科门诊对有症状的良性前列腺增生(BPH)进行药物治疗的疗效。本研究选取了70例年龄在50 - 80岁、出现下尿路症状且临床诊断为BPH的患者,这些患者经过精心匹配。其中,36例患者(第一组)和34例患者(第二组)分别接受坦索罗辛(每日一次,0.4毫克)和非那雄胺(每日一次,5毫克)治疗,为期6个月。基于国际前列腺症状评分(IPSS)和最大尿流率(Qmax)比较两种药物的疗效。两组的基线参数在统计学上无显著差异。两组在治疗6个月后,IPSS和Qmax均有显著改善(P<0.001)。在第1、2、4和6个月的随访期间,两组的IPSS和Qmax均有显著改善(p<0.001)。还观察到坦索罗辛比非那雄胺能更快地改善IPSS和Qmax。